BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37844234)

  • 1. Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.
    Ng A; Lovat F; Shih AJ; Ma Y; Pekarsky Y; DiCaro F; Crichton L; Sharma E; Yan XJ; Sun D; Song T; Zou YR; Will B; Croce CM; Chiorazzi N
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2308658120. PubMed ID: 37844234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
    Han YC; Park CY; Bhagat G; Zhang J; Wang Y; Fan JB; Liu M; Zou Y; Weissman IL; Gu H
    J Exp Med; 2010 Mar; 207(3):475-89. PubMed ID: 20212066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of both miR-15/16 loci induces acute myeloid leukemia.
    Lovat F; Fassan M; Sacchi D; Ranganathan P; Palamarchuk A; Bill M; Karunasiri M; Gasparini P; Nigita G; Distefano R; Veneziano D; Dorrance AM; Garzon R; Croce CM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):13069-13074. PubMed ID: 30478046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.
    Lovat F; Nigita G; Distefano R; Nakamura T; Gasparini P; Tomasello L; Fadda P; Ibrahimova N; Catricalà S; Palamarchuk A; Caligiuri MA; Gallì A; Malcovati L; Minden MD; Croce CM
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12332-12340. PubMed ID: 32424097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-15b/16-2 deletion promotes B-cell malignancies.
    Lovat F; Fassan M; Gasparini P; Rizzotto L; Cascione L; Pizzi M; Vicentini C; Balatti V; Palmieri D; Costinean S; Croce CM
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11636-41. PubMed ID: 26324892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.
    Morris VA; Zhang A; Yang T; Stirewalt DL; Ramamurthy R; Meshinchi S; Oehler VG
    PLoS One; 2013; 8(9):e75815. PubMed ID: 24086639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
    Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
    FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Liu J; Guo B; Chen Z; Wang N; Iacovino M; Cheng J; Roden C; Pan W; Khan S; Chen S; Kyba M; Fan R; Guo S; Lu J
    Blood; 2017 Mar; 129(11):1491-1502. PubMed ID: 28053194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
    Gentner B; Pochert N; Rouhi A; Boccalatte F; Plati T; Berg T; Sun SM; Mah SM; Mirkovic-Hösle M; Ruschmann J; Muranyi A; Leierseder S; Argiropoulos B; Starczynowski DT; Karsan A; Heuser M; Hogge D; Camargo FD; Engelhardt S; Döhner H; Buske C; Jongen-Lavrencic M; Naldini L; Humphries RK; Kuchenbauer F
    Exp Hematol; 2015 Oct; 43(10):858-868.e7. PubMed ID: 26163797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
    Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
    Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
    Hartmann JU; Bräuer-Hartmann D; Kardosova M; Wurm AA; Wilke F; Schödel C; Gerloff D; Katzerke C; Krakowsky R; Namasu CY; Bill M; Schwind S; Müller-Tidow C; Niederwieser D; Alberich-Jorda M; Behre G
    Cell Death Dis; 2018 Jul; 9(8):814. PubMed ID: 30050105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.
    O'Connell RM; Rao DS; Chaudhuri AA; Boldin MP; Taganov KD; Nicoll J; Paquette RL; Baltimore D
    J Exp Med; 2008 Mar; 205(3):585-94. PubMed ID: 18299402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mirn23a and mirn23b microrna clusters are necessary for proper hematopoietic progenitor cell production and differentiation.
    Kurkewich JL; Boucher A; Klopfenstein N; Baskar R; Kapur R; Dahl R
    Exp Hematol; 2018 Mar; 59():14-29. PubMed ID: 29288704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-15a/16-1 and miR-15b/16-2 clusters regulate early B cell development by limiting IL-7 receptor expression.
    Hutter K; Rülicke T; Szabo TG; Andersen L; Villunger A; Herzog S
    Front Immunol; 2022; 13():967914. PubMed ID: 36110849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.